Search bioRxivSearch

bioRxiv · 10.1101/2020.07.09.191734

HIP1 mediates oncogenic transformation and cancer progression through STAT3 signalling

Abstract

Background Huntingtin-interacting protein 1 (HIP1) is an adaptor protein involved in transcriptional regulation and receptor-mediated endocytosis. Overexpression of HIP1 transforms cell and is associated with, increasing grades of prostate cancer (CaP) and poor patient outcomes. However, the precise mechanism for the role of HIP1 in prostate cancer progression remains unknown.Methods Using a phospho-kinase antibody array we identified changes in signalling associated with HIP1 overexpression PNT1 cells. For validation Western blots were used together with knockdown or inhibitor treatments and phenotypic assays for cellular transformation. The cell line was xenografted to assess tumour growth. Gene expression microarray analysis of the cell line was used to identify perturbations in transcript levels.Results Here we demonstrate cellular transformation and phenotypic effects of HIP1 overexpression in a benign prostate epithelial cell line to be dependent on STAT3 signalling. In vivo xenografts confirmed the cellular transformation phenotype. Gene expression analysis revealed serum protein GDF15 to be a marker of prostate cancer tumorigenesis in our model. We present a HIP1-STAT3-GDF15 axis in our pre-clinical model that mediates cellular transformation and tumorigenesis.Conclusion Our findings provide a model defining the functional effects of increased HIP1 expression in prostate tumorigenesis and progression. This model implicates increased STAT3 signalling in HIP1-dependent prostate carcinogenesis and identifies GDF15 as a secreted factor supporting this process. The role of HIP1-STAT3-GDF15 signalling may extend to other epithelial cancers shown to overexpress HIP1; such as gliomas, colon and breast cancer where STAT3 is an emerging oncology drug target.Competing Interest StatementThe authors have declared no competing interest.AbbreviationsHIP1Huntingtin-interacting protein 1CaPprostate cancerSTAT3Signal transducer and activator of transcription 3kDakilo DaltonFGFfibroblast growth factorFGFRfibroblast growth factor receptorGDF15Growth Differentiation Factor 15ARandrogen receptorGFPgreen fluorescent proteinHRPhorse radish peroxidaseqRT-PCRquantitative real time polymerase chain reactionGAPDHGlyceraldehyde 3-phosphate dehydrogenaseEVempty vectorshRNAshort hairpin ribonucleic acidRPMIRoswell Park Memorial InstituteFCSfoetal calf serummRNAmessenger ribonucleic acidsiRNASmall interfering ribonucleic acidPMSFPhenylmethanesulfonyl fluoridDTTDithiothreitolEDTAEthylenedinitrilotetraacetic acidSDS-PAGEsodium dodecyl sulfate-polyacrylamide gel electrophoresisPVDFPolyvinylidene difluorideRFUrelative fluorescence unitAMPK1αProtein kinase AMP-activated catalytic subunit alpha 1PLC-γ1Phospholipase C-γ1MEK1Mitogen-activated protein kinase kinase 1JAK2Janus kinase 2DMSODimethyl sulfoxideERK1/2extracellular signal-regulated protein kinase ½DEGdifferentially expressed geneTGF-betatransforming growth factor-betaELISAenzyme-linked immunosorbent assayIgGImmunoglobulin GRTKsreceptor tyrosine kinasesEGFRepidermal growth factor receptorISGF3Interferon stimulated gene factor 3IRF9Interferon regulatory factor 9DNMT1DNA (cytosine-5)-methyltransferase 1HDACHistone deacetylaseSTINGstimulator of interferon genesGFRALGlial cell-derived neurotrophic factor Family Receptor Alpha LikeRETrearranged during transfectionCFLARCASP8 and FADD-Like Apoptosis RegulatorView Full Text

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Roheet Bantval Rao, Antonio Ramos-Montoya, Helen Scott, Lorraine Berry, Stefanie Reichelt, Stewart MacArthur, Roslin Russell, David E Neal, Emma Evergren, Ian G Mills. 2020-07-09. HIP1 mediates oncogenic transformation and cancer progression through STAT3 signalling. https://doi.org/10.1101/2020.07.09.191734

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Ex vivo human tumor slices more accurately predict patient responses to an oncolytic virus than in vivo mouse models

Immunotherapies, including oncolytic viruses (OV), are promising therapies that can enhance anti-tumor immune responses. However, preclinical success of immunotherapies in mouse models has not always translated to clinical benefit in cancer patients. This study compared preclinical efficacy and mechanism of action for ASP9801, a vaccinia virus expressing IL-7 and IL-12, using mouse models of colorectal cancer (CRC) in vivo and in human organotypic tumor slice models ex vivo. The murine surrogate for ASP9801 significantly reduced tumor volumes in treated and abscopal tumors in two different CRC models in vivo (MC38 and RO100). Treatment efficacy was accentuated when combined with anti-PD1 treatment, and single-cell RNA sequencing analysis revealed depletion of tumor cells and increased T cell infiltration and activation in both treated and abscopal tumors. However, human tissue analysis ex vivo (E-slices) using PDX models and patient samples showed that ASP9801 is not effective in CRC, consistent with clinical trial results. On the other hand, ASP9801 was highly effective in GBM, indicating indication-specific efficacy of ASP9801, and how E-slice assays can be used to identify treatment-sensitive indications. This study demonstrates the superiority of E-slices over mouse models for predicting clinical response and its utility in planning clinical trials.

cancer biology

Immune-cell depleted diffuse large B-cell lymphomas have reduced expression of MHC class I

Immunotherapy has transformed treatment for many cancers. In the aggressive and genetically heterogeneous diffuse large B-cell lymphoma (DLBCL), CD19 CAR T-cell therapy is highly effective, whereas immune checkpoint blockade has shown limited benefit. Loss of MHC expression is a common mechanism to escape T-cell cytotoxicity, and loss of MHC class I (MHC-I) and II are frequent in DLBCL. We applied imaging mass cytometry to diagnostic biopsies from younger, high-risk DLBCL patients to map the tumor microenvironment (TME) spatial architecture in relation to tumor cell MHC expression, mutational status, transcriptomic and proteomic profiles. Neighborhood analyses identified four TME subtypes: immune-cell depleted and three immune-infiltrated types (mixed, CD4 T cell-rich, CD8 T-cell/macrophage-rich). Depleted cases had shorter overall survival (p = 0.033) and increased expression of proteins involved in DNA replication and proliferation markers compared to infiltrated cases. Tumor cell MHC-I expression was heterogeneous. Cases with low frequency of MHC-I-pos tumor cells were enriched for the depleted TME type. MHC-I-pos tumor cells were surrounded by CD4 and CD8 T cells and M1 macrophages, whereas MHC-I-neg tumor cells were closer to other MHC-I-neg tumor cells. These findings suggest that TME-based classification incorporating tumor cell MHC-I status may improve individualized immunotherapy selection.

cancer biology

Cross-species analysis links cell-cell communication rewiring to NOTCH2 during serous endometrial carcinogenesis

Cell-cell interactions shape the fate of mutant cells during cancer initiation but how these interactions evolve during progression to pathologically recognizable lesions remain poorly understood. Here, we investigated cell-cell communication during serous endometrial carcinoma (SEC; also known as uterine serous carcinoma) development using a lineage-traceable mouse model and cross-species analyses of the mouse and human neoplastic endometrium. In mice, the early, pre-dysplastic stage was marked by a global decrease in inferred cell-cell interactions, followed by extensive communication network rewiring during neoplastic progression. Pathway-specific analysis revealed a similar pattern for NOTCH signaling, with NOTCH2 emerging as the dominant NOTCH receptor in Trp53/Rb1-mutant immature epithelial cells. Functionally, NOTCH2 promoted the outgrowth of more proliferative mutant organoids. Cross-species transcriptomic analysis identified conserved immature epithelial states in mouse and human neoplastic endometrial epithelium. In human tissues, NOTCH2 was overexpressed in serous endometrial intraepithelial carcinoma, a precursor of SEC, and in overt SEC. Furthermore, elevated NOTCH2 expression was associated with poor patient survival. These findings link cell-cell communication rewiring during experimental SEC development to conserved neoplastic epithelial states and identify NOTCH2 as an early marker and a potential target of disease interception.

cancer biology